SPDYE9: A Potential Drug Target and Biomarker for Cell Cycle Regulation

Target Name: SPDYE9

NCBI ID: G643909

SPDYE9

Other Name(s): speedy/RINGO cell cycle regulator family member E9 | Speedy/RINGO cell cycle regulator family member E9, pseudogene | Williams Beuren syndrome chromosome region 19 pseudogene | speedy/RINGO cell cycle regulator family member E1 pseudogene | SPDYE9P | speedy homolog E1 pseudogene | speedy homolog E9, pseudogene | speedy/RINGO cell cycle regulator family member E9, pseudogene

SPDYE9: A Potential Drug Target and Biomarker for Cell Cycle Regulation

The Speedy/RINGO Cell Cycle Regulatory Family Member E9

The Speedy/RINGO cell cycle regulatory family is a family of proteins that play a crucial role in regulating the cell cycle. This family includes eight proteins, including SPDYE9, which are characterized by the presence of a specific domain called N-terminal alpha-helices . The function of these proteins is to regulate the movement of chromosomes through the cell cycle, ensuring proper cell division and growth.

SPDYE9, also known as SPDYE9-like, is a protein that belongs to the Speedy/RINGO family. This protein is expressed in various cell types, including neurons, and it is involved in regulating the cell cycle. SPDYE9 functions by interacting with the nuclear Kernel and ribosomes, which are important organelles that are responsible for the production of proteins in the cell.

The N-terminal alpha-helices of SPDYE9 are crucial for its function. These alpha-helices form a structure that is involved in the regulation of the cell cycle. They interact with the nuclear kernel and ribosomes, which are important organelles that are responsible for the production of proteins in the cell. This interaction between SPDYE9 and the nuclear kernel and ribosome allows the protein to regulate the cell cycle.

SPDYE9 is a protein that is expressed in various cell types, including neurons. It is involved in regulating the cell cycle by interacting with the nuclear kernel and ribosome. This interaction between SPDYE9 and the nuclear kernel and ribosome allows the protein to regulate the cell cycle.

SPDYE9 is also a potential drug target. The Speedy/RINGO family of proteins has been shown to be involved in various cellular processes, including cell division, growth, and differentiation. This suggests that SPDYE9 may be a useful target for new drugs that can be used to treat various diseases.

In addition to its potential drug target properties, SPDYE9 is also a biomarker. The Speedy/RINGO family of proteins has been shown to be involved in various cellular processes, including cell division, growth, and differentiation. This suggests that SPDYE9 may be a useful biomarker for various diseases.

Conclusion

In conclusion, SPDYE9 is a protein that is involved in regulating the cell cycle. It functions by interacting with the nuclear kernel and ribosomes, which are important organelles that are responsible for the production of proteins in the cell. The N-terminal alpha- helices of SPDYE9 form a structure that is involved in the regulation of the cell cycle.

SPDYE9 is a potential drug target and biomarker. Its involvement in various cellular processes makes it a promising target for new drugs that can be used to treat various diseases. Further research is needed to fully understand the function of SPDYE9 and its potential as a drug target and biomarker.

Protein Name: Speedy/RINGO Cell Cycle Regulator Family Member E9

The "SPDYE9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPDYE9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets